UNSPSC 85501422: Supplement left vertebral artery with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left vertebral artery with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03UQ4JZ

UNSPSC 85501422 Supplement left vertebral artery with synthetic substitute, percutaneous endoscopic approach is a Commodity code describing a specific surgical procedure, but the recent state and local contract opportunities posted under this code show no alignment with the procedure itself. Instead, the opportunities reflect a broad portfolio of health benefits administration, occupational and disability medical services, pharmacy management, and temporary clinical staffing—none involving vertebral artery augmentation. The City of Phoenix Retirement Office solicited independent medical evaluation services for disability pension determinations; the City of Long Beach requested a surgical carve-out benefit program managing Centers of Excellence networks for multiple procedure types; the Washington State Department of Transportation sought occupational medical surveillance for ferry workers; Harris County Juvenile Probation Department issued an RFI for emergency and specialty hospital services for detained youth; Collier County sought pharmacy benefit management covering approximately 2,400 employees and 4,800 covered dependents; and Santa Clara County Health System established a qualified vendor pool for temporary ancillary clinical staffing. The issuing bodies span state departments, county health and human services divisions, city retirement and employee benefits offices, and special-purpose health systems. The geographic spread includes Arizona, California, Florida, and Washington.

The mismatch between the code's nominal description and the actual recent opportunities suggests this code carries little or no relevant procurement activity for firms pursuing vascular surgical implant contracts or related medical device and surgical services. The opportunities that do appear under the code reflect state and local government purchasing in medical administration, benefits consulting, occupational health compliance, and temporary workforce augmentation—categories disconnected from the implant procedure the code nominates. Vendors evaluating this code should verify whether the opportunities represent a data classification error or whether the code genuinely absorbs unrelated health-sector purchasing, and should monitor for future activity alignment before committing business development resources.